18
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Drug adherence and clinical outcomes for patients under pharmacological therapy for lower urinary tract symptoms related to benign prostatic hyperplasia: population-based cohort study.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Little is known about drug adherence in men treated for lower urinary tract symptoms (LUTS). Benign prostatic hyperplasia (BPH) is one of the causes of LUTS.

          Related collections

          Author and article information

          Journal
          Eur. Urol.
          European urology
          1873-7560
          0302-2838
          Sep 2015
          : 68
          : 3
          Affiliations
          [1 ] Department of Urology, S. Pio da Pietrelcina Hospital, Vasto, Italy. Electronic address: lucacindolo@virgilio.it.
          [2 ] Department of Clinical Pharmacology and Epidemiology, Fondazione Mario Negri Sud, Santa Maria Imbaro, Italy.
          [3 ] Department of Urology, Ospedale Sant'Andrea, University La Sapienza, Rome, Italy.
          [4 ] University Hospitals, Urology Institute, Cleveland, OH, USA.
          [5 ] Department of Urology, S. Pio da Pietrelcina Hospital, Vasto, Italy.
          Article
          S0302-2838(14)01180-4
          10.1016/j.eururo.2014.11.006
          25465970
          329cff8c-9185-4910-be3d-4b58deb2762d
          Copyright © 2014 European Association of Urology. Published by Elsevier B.V. All rights reserved.
          History

          5-Alpha reductase inhibitors,Administrative database,Alpha blockers,Benign prostatic hyperplasia,Drug adherence,Drug therapy,Lower urinary tract symptoms

          Comments

          Comment on this article